Lupin gets FDA OK for generic Mycolog-II cream
The Food and Drug Administration has approved Lupin’s generic Mycolog II cream (nystatin and triamcinolone acetonide cream, 100,000 units/g and 1 mg/g). The product is indicated to treat cutaneous candidiasis.
The generic Mycolog-II cream enters a market whose size was roughly $62.2 million for the 12 months ended April 2018.
The generic Mycolog-II cream enters a market whose size was roughly $62.2 million for the 12 months ended April 2018.